Previous Article | Next Article ![]()
Infection and Immunity, March 1999, p. 1505-1507, Vol. 67, No. 3
Department of Medical Microbiology,
University of Wales College of Medicine, Heath Park, Cardiff CF4
4XN, United Kingdom
Received 15 June 1998/Returned for modification 26 August
1998/Accepted 19 November 1998
Whole cells and lipopolysaccharides (LPSs) extracted from
Burkholderia cepacia, Pseudomonas aeruginosa,
Stenotrophomonas maltophilia, and Escherichia
coli were compared in their ability to stimulate tumor necrosis
factor alpha (TNF-
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Lipopolysaccharide (LPS) from Burkholderia
cepacia Is More Active than LPS from Pseudomonas
aeruginosa and Stenotrophomonas maltophilia in
Stimulating Tumor Necrosis Factor Alpha from Human Monocytes
) from the human monocyte cell line MonoMac-6.
B. cepacia LPS, on a weight-for-weight basis, was found to
have TNF-
-inducing activity similar to that of LPS from E. coli, which was approximately four- and eightfold greater than
the activity of LPSs from P. aeruginosa and S. maltophilia, respectively. The LPS-stimulated TNF-
production
from monocytes was found to be CD14 dependent. These results suggest
that B. cepacia LPS might play a role in the pathogenesis
of inflammatory lung disease in cystic fibrosis, and in some patients
it might be responsible, at least in part, for the sepsis-like cepacia syndrome.
*
Corresponding author. Mailing address: Department of
Medical Microbiology, University of Wales College of Medicine, Heath Park, Cardiff CF4 4XN, United Kingdom. Phone: 44 1222 744725. Fax: 44 1222 742161. E-mail: JacksonSK{at}CF.AC.UK.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|